Physician profile
John Ho Pak
NPI 1598736068
$6,386.28
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,994 · 2020: $295 · 2021: $170 · 2022: $533 · 2023: $1,557 · 2024: $1,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,825 · Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,824.88 |
| Food and Beverage | $1,569.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $2,595.46 | 2023-2024 | Inset System |
| Arthrex, INC. | $986.12 | 2019 | |
| Conformis, INC. | $903.59 | 2019-2022 | |
| Smith+Nephew, INC. | $649.56 | 2020-2024 | Bone Anchors With Arthroscopic Delivery System, Spatial Frame, Healicoil |
| Stryker Corporation | $561.14 | 2022-2024 | Blueprint Patient Specific Instrumentation, Iconix, Procinch |
| Gemini Mountain Medical, LLC | $516.80 | 2019-2021 | |
| Pacira Therapeutics, INC. | $122.66 | 2019 | |
| Becton, Dickinson and Company | $35.87 | 2024 | |
| Depuy Synthes Sales INC. | $15.08 | 2024 | Monovisc, Orthovisc |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,559.17 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.